Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer
Clinical trial NCT01550055 · COMPLETED
Trial details
- NCT number
- NCT01550055
- Sponsor
- Shanghai Zhangjiang Biotechnology Limited Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-31
- Primary completion
- 2012-12-23
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.